Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xtant Medical Holdings (XTNT) Depreciation & Amortization - Total (2016 - 2019)

Xtant Medical Holdings (XTNT) has disclosed Depreciation & Amortization - Total for 9 consecutive years, with $800000.0 as the latest value for Q3 2019.

  • On a quarterly basis, Depreciation & Amortization - Total changed 0.0% to $800000.0 in Q3 2019 year-over-year; TTM through Jun 2020 was $800000.0, a 74.19% decrease, with the full-year FY2018 number at $3.2 million, down 15.79% from a year prior.
  • Depreciation & Amortization - Total was $800000.0 for Q3 2019 at Xtant Medical Holdings, up from $700000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization - Total ranged from a high of $2.0 million in Q3 2017 to a low of -$100000.0 in Q4 2017.
  • A 5-year average of $653061.0 and a median of $747850.0 in 2016 define the central range for Depreciation & Amortization - Total.
  • Peak YoY movement for Depreciation & Amortization - Total: plummeted 139.99% in 2017, then skyrocketed 900.0% in 2018.
  • Xtant Medical Holdings' Depreciation & Amortization - Total stood at $112750.0 in 2015, then soared by 121.8% to $250078.0 in 2016, then tumbled by 139.99% to -$100000.0 in 2017, then surged by 900.0% to $800000.0 in 2018, then changed by 0.0% to $800000.0 in 2019.
  • Per Business Quant, the three most recent readings for XTNT's Depreciation & Amortization - Total are $800000.0 (Q3 2019), $700000.0 (Q2 2019), and $800000.0 (Q1 2019).